Suvretta Capital Management
Suvretta Capital Management is an investment management company.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Suvretta Capital Management Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Crunchbase
Metrics
5,011,257Website Global Rank
1,758Website Monthly Traffic
Twitter Followers
Description
Suvretta Capital Management is an investment management company.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 1/2021 | Terns Pharmaceuticals | Series C | 87M |
| 7/2020 | Molecular Partners | Post-IPO Equity | 0 |
| 7/2022 | Prokidney | Post-IPO Equity | 205M |
| 2/2021 | HemoShear Therapeutics | Series A | 40M |
| 2/2021 | Gemini Therapeutics | Post-IPO Equity | 0 |
| 7/2021 | Alight Solutions | Post-IPO Equity | 0 |
| 10/2021 | Roivant Sciences | Post-IPO Equity | 0 |
| 12/2021 | Freenome | Series D | 300M |
| 6/2021 | Turntide Technologies | Convertible Note | 225M |
| 11/2020 | Ambrx | Private Equity Round | 200M |
| 3/2021 | Paysafe | Post-IPO Equity | 0 |
| 2/2021 | Pipeline Therapeutics | Series C | 0 |
| 7/2021 | Point Biopharma | Post-IPO Equity | 0 |
| 9/2020 | BioShin | Series A | 60M |
| 12/2021 | connectRN | Venture Round | 0 |
| 12/2020 | Solid Biosciences | Post-IPO Equity | 0 |
| 7/2022 | Prokidney | Post-IPO Equity | 0 |
| 12/2021 | connectRN | Venture Round | 0 |
| 12/2021 | Freenome | Series D | 0 |
| 10/2021 | Roivant Sciences | Post-IPO Equity | 0 |
| 7/2021 | Alight Solutions | Post-IPO Equity | 0 |
| 7/2021 | Point Biopharma | Post-IPO Equity | 0 |
| 6/2021 | Turntide Technologies | Convertible Note | 0 |
| 3/2021 | Paysafe | Post-IPO Equity | 0 |
| 2/2021 | Pipeline Therapeutics | Series C | 0 |
| 2/2021 | HemoShear Therapeutics | Series A | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
